No CrossRef data available.
Patients’ knowledge and awareness about patient support programs: a cross-sectional study on Lebanese adults with chronic diseases
Published online by Cambridge University Press: 02 February 2021
Abstract
Objective
Patient Support Programs (PSPs) have become a trend among pharmaceutical companies and a standard service offering to patients. The objective of the present study is to describe the status of PSPs in Lebanon and to assess the extent of knowledge and awareness among Lebanese patients about the PSPs.
Methods
A cross-sectional study was conducted between April and July 2017. A convenient sample of patients was randomly selected from outpatient clinics at four hospitals within the Greater Beirut Area. A questionnaire was used to address the study objective. Bivariate analysis was performed using the Chi-square test. Data were analyzed by using SPSS version 23.
Results
Out of 385 patients who participated in the study, 45.45 percent were aged between 46 and 66 years. None of them indicated that they were enrolled in a PSP, and only 13 percent of the respondents were aware of the existence of such a program. In terms of adherence habits, 55.6 percent of the patients self-reported that they do not skip any dose of their medication and consume their medication as prescribed by their healthcare providers. The main reason for nonadherence reported by the majority of nonadherent participants 144 (84.2%) was simple forgetfulness.
Conclusions
There is a severe lack of awareness of PSPs in Lebanon. Given the important role that PSPs play in creating value for patients—in terms of healthcare follow-up practices, improved adherence habits, and cost savings—there should be a more substantial effort by pharmaceutical companies to expand and promote their PSPs in the Lebanese market.
- Type
- Assessment
- Information
- Copyright
- Copyright © The Author(s), 2021. Published by Cambridge University Press
References
Wang, H, Naghavi, M, Allen, C. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–544.CrossRefGoogle Scholar
Giardini, A, Martin, M, Cahir, C, Lehane, E, Menditto, E, Strano, M, et al. Towards appropriate criteria in medication adherence assessment in older persons: Position paper. Aging Clin Exp Res. 2016;28:371–81. doi:10.1007/s40520–015–0435-z.CrossRefGoogle Scholar
Viswanathan, M, Golin, C, Jones, C, Ashok, M, Blalock, S, Wines, R, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: A systematic review. Ann Intern Med. 2012;157:785–95. doi:10.7326/0003-4819-157-11-201212040-00538.CrossRefGoogle ScholarPubMed
Hugh, W, Marlon, G. The cost of chronic diseases in the U.S. executive summary. May 2018.Google Scholar
World Health Organization. Global action plan for the prevention and control of non-communicable diseases 2013–2020. 2013.Google Scholar
Georgopoulou, S, Prothero, L, Lempp, H, Galloway, J, Sturt, J. Motivational interviewing: relevance in the treatment of rheumatoid arthritis? Rheumatology (Oxford). 2016;55:1348–56. doi:10.1093/rheumatology/kev379.CrossRefGoogle ScholarPubMed
Ganguli, A, Clewell, J, Shillington, C. The impact of patient support programs on adherence, clinical, humanistic, and economic patient outcomes: A targeted systematic review. Patient Prefer Adherence. 2016;10:711–25.Google ScholarPubMed
ABPI. Guidance notes for patient safety and pharmacovigilance in Patient Support Programmes 2011. Report.Google Scholar
Koselke, E, Marini, B, Kraft, S, Walker, S, Allore, D, Mackler, E. Implementation of and satisfaction with an outpatient oral anticancer therapy program. J Hematol Oncol Pharm. 2015;5:62–8.Google Scholar
Stockl, M, Shin, S, Lew, C, Zakharyan, A, Harada, A, Solow, B, et al. Outcomes of a rheumatoid arthritis disease therapy management program focusing on medication adherence. J Manag Care Pharm. 2010;16:593–604. doi:10.18553/jmcp.2010.16.8.593.CrossRefGoogle ScholarPubMed
WHO. Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization; 2003.Google Scholar
New York Department of Health. Chronic diseases and conditions. New York: Department of Health. Revised May 2016. Available from: https://www.health.ny.gov/diseases/chronic/.Google Scholar
Romito, A, Pressburger, R, Wiedenhoft, E. Accenture. Patient services. The patient is in pharma's growing opportunity in patient services. Accenture. 2016. Available from: https://www.accenture.com/in-en/_acnmedia/Accenture/next-gen-2/patient-services-survey-pharma/pdf/Accenture-patient-services-2016-survey-results-web.pdf.Google Scholar
Lenz, F, Harms, L. The impact of patient support programs on adherence to disease-modifying therapies of patients with relapsing-remitting multiple sclerosis in germany: A non-interventional, prospective study. Adv Ther. 2020;3:2999–3009. doi:10.1007/s12325-020-01349-3.CrossRefGoogle Scholar
Sato, M, Tsujimoto, M, Kajimoto, K, Uetake, H, Shimoda, H, Fujiwara, S. Effect of a patient-support program on once-daily teriparatide adherence and persistence in the Japan Fracture Observational Study (JFOS). Arch Osteoporos. 2018;13:74. Epub 2018/07/05. doi:10.1007/s11657-018-0487-8.CrossRefGoogle Scholar
Brixner, D, Mittal, M, Rubin, T, Mease, P, Liu, H, Davis, M, et al. Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population. Patient Prefer Adherence. 2019;1:1545–56. doi:10.2147/PPA.S215037.CrossRefGoogle Scholar
Van den Bosch, F, Ostor, K, Wassenberg, S, Chen, N, Wang, C, Garg, V, et al. Impact of participation in the adalimumab (humira) patient support program on rheumatoid arthritis treatment course: Results from the PASSION Study. Rheumatol Ther. 2017;4:85–96. doi:10.1007/s40744-017-0061-7.CrossRefGoogle ScholarPubMed
Jin, G, Zhao, Y, Chen, C, Wenji, W, Juan, D, Xiaoqin, L. The length and content of general practice consultation in two Urban districts of Beijing: A preliminary observation study. PLoS ONE. 2015;10:e0135121. doi:10.1371/journal.pone.0135121.CrossRefGoogle ScholarPubMed
Fitri, E, Sari, K. The relationship between consultation length and patient satisfaction: A systematic review. KnE Life Sci. 2018;4:41–9. doi:10.18502/kls.v4i9.3556.CrossRefGoogle Scholar
Lorig, R, Sobel, S, Ritter, L, Laurent, D, Hobbs, M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2001;4:256–62.Google ScholarPubMed
Kaur, R, Kajal, S, Kaur, A, Singh, P. Telephonic consultation and follow-up in diabetics: Impact on metabolic profile, quality of life, and patient compliance. North Am J Med Sci. 2015;7:199–207.CrossRefGoogle ScholarPubMed
Houser, H, Ray, N, Maisiak, R, Panjamapirom, A, Willing, J, Schiff, G, et al. Telephone follow-up in primary care: Can interactive voice response calls work? Stud Health Technol Inform. 2013;192:112–16.Google ScholarPubMed
Rubin, T, Mittal, M, Davis, M, Johnson, S, Chao, J, Skup, M. Impact of a patient support program on patient adherence to adalimumab and direct medical costs in Crohn's disease, ulcerative colitis, rheumatoid arthritis, psoriasis, psoriatic arthritis, and ankylosing spondylitis. J Manag Care Spec Pharm. 2017;23:859–67. doi:10.18553/jmcp.2017.16272.Google ScholarPubMed
Adis, R, Martins, A, Fakeye, O. Factors contributing to non-adherence to oral hypoglycemic medications among ambulatory type 2 diabetes patients in Southwestern Nigeria. Pharm Pract. 2009;7:163–9.Google Scholar
Zafar, Y, Peppercorn, M. Patient financial assistance programs: A path to affordability or a barrier to accessible cancer care? J Clin Oncol. 2017;35:2113–16. doi:10.1200/JCO.2016.71.7280.CrossRefGoogle ScholarPubMed